Scientific Program| DNA Analysis | Genomics

Metropolis Healthcare Expands North India Footprint with Strategic Acquisition of Dr. Ahujas’ Pathology & Imaging Centre

2025-04-28 - 2025-04

In a significant move to bolster its presence in North India, Metropolis Healthcare Limited, one of India’s leading diagnostic chains, announced the acquisition of Dehradun’s premier diagnostic provider, Dr. Ahujas’ Pathology & Imaging Centre (DAPIC). The acquisition was executed through Metropolis’ wholly owned subsidiary, Metropolis Histoxpert Digital Services Private Limited, via a business transfer agreement.

Established in 1990 by Dr. Alok Ahuja and Dr. Alka Ahuja, DAPIC has become a trusted name in Uttarakhand’s diagnostic landscape. Known for its clinical excellence and patient trust, the chain comprises two NABL and NABH accredited laboratories, 11 patient service centres, and nine hospital-based centres, offering a comprehensive range of pathology and soft radiology services including ultrasound, ECG, and X-ray.

Mindpeak and DigitCells Forge Alliance to Advance AI-Powered Digital Pathology Workflows: A Paradigm Shift for Diagnostic Precision and Efficiency

2025-04-25 - 2025-04

Chicago, IL, April 21, 2025 (GLOBE NEWSWIRE) -- DigitCells, an innovator at the forefront of comprehensive pathology solutions, and Mindpeak, a pioneering force in artificial intelligence-driven pathology software, today announced a partnership. This strategic collaboration will integrate Mindpeak's cutting-edge AI algorithms into DigitCells' advanced digital pathology platform, ushering in a new era of enhanced efficiency, diagnostic accuracy, and workflow optimization for pathology laboratories nationwide.

Patient Case Study: Second Opinion Reveals Misdiagnosed Cancer

2025-04-23 - 2025-04

A young man traveled from his home in South Carolina to Cleveland Clinic for a second opinion about his presumed diagnosis of stage 4 cholangiocarcinoma after developing end-stage liver failure from radioembolizations performed elsewhere. Upon reviewing his case, the Cleveland Clinic pathologist made a startling discovery: The patient did not have cholangiocarcinoma but in fact had a rare, indolent cancer called epithelioid hemangioendothelioma (EHE)..

Beyond CRISPR: Scientists Develop New Tool for Cutting DNA

2025-04-22 - 2025-04

A few years ago, the introduction of CRISPR technology marked a significant breakthrough in the scientific community. Derived from a component of the bacterial immune system, CRISPR enables precise cuts in double-stranded DNA, allowing scientists to modify specific genes in plants, animals, and humans. This precision has made CRISPR a leading tool in the development of treatments for both inherited and acquired diseases.

A clinical benchmark of public self-supervised pathology foundation models

2025-04-21 - 2025-04

The use of self-supervised learning to train pathology foundation models has increased substantially in the past few years. Notably, several models trained on large quantities of clinical data have been made publicly available in recent months. This will significantly enhance scientific research in computational pathology and help bridge the gap between research and clinical deployment. With the increase in availability of public foundation models of different sizes, trained using different algorithms on different datasets, it becomes important to establish a benchmark to compare the performance of such models on a variety of clinically relevant tasks spanning multiple organs and diseases.

US Digital Pathology Market worth US$2.01 billion by 2029 with 13.1% CAGR

2025-04-19 - 2025-04

By Based on Scanners segment, In the US, the digital pathology market is classified based on type into scanners, software, and storage systems. In 2023, the scanners segment accounted for the largest share of the product segment. The high demand for scanners is attributed to continuous technical improvements, such as improved imaging resolution, increased scanning speeds, and greater automation capabilities. Such innovations have optimized pathology workflows, saving time and labour costs, rendering scanners a key tool in contemporary US pathology laboratories.

A clinical benchmark of public self-supervised pathology foundation models

2025-04-17 - 2025-04

Webinar on DNA Analysis and Pathology

useful links

Latest News

Metropolis Healthcare Expands North India Footprint with Strategic Acquisition of Dr. Ahujas’ Pathology & Imaging Centre

Mindpeak and DigitCells Forge Alliance to Advance AI-Powered Digital Pathology Workflows: A Paradigm Shift for Diagnostic Precision and Efficiency

Patient Case Study: Second Opinion Reveals Misdiagnosed Cancer

Beyond CRISPR: Scientists Develop New Tool for Cutting DNA

A clinical benchmark of public self-supervised pathology foundation models

US Digital Pathology Market worth US$2.01 billion by 2029 with 13.1% CAGR

A clinical benchmark of public self-supervised pathology foundation models

support@globalmeetx.net

+44-7477-467410